Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 379 contracts
Sources: Underwriting Agreement (Precigen, Inc.), Underwriting Agreement (Intra-Cellular Therapies, Inc.), Underwriting Agreement (Coherus BioSciences, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Stock as described in the Registration Statement, the Pricing General Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 102 contracts
Sources: Underwriting Agreement (Avidity Biosciences, Inc.), Underwriting Agreement (Senseonics Holdings, Inc.), Underwriting Agreement (Humacyte, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Public Units as described in the Registration Statement, the Pricing General Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 40 contracts
Sources: Underwriting Agreement (Silver Pegasus Acquisition Corp.), Underwriting Agreement (Silver Pegasus Acquisition Corp.), Underwriting Agreement (Timber Road Acquisition Corp)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governorsthe Federal Reserve.
Appears in 39 contracts
Sources: Underwriting Agreement (Horizon Bancorp Inc /In/), Underwriting Agreement (Northpointe Bancshares Inc), Underwriting Agreement (Eagle Financial Services Inc)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 34 contracts
Sources: Underwriting Agreement (Synovus Financial Corp), Underwriting Agreement (ImmunoGen, Inc.), Underwriting Agreement (Otonomy, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governorsthe Federal Reserve.
Appears in 27 contracts
Sources: Underwriting Agreement (Simmons First National Corp), Underwriting Agreement (SouthState Corp), Underwriting Agreement (ConnectOne Bancorp, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package Statement and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 25 contracts
Sources: Open Market Sale Agreement (ImmunoGen, Inc.), Open Market Sale Agreement (ImmunoGen, Inc.), Sales Agreement (Conformis Inc)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities as described in the Registration Statement, the Pricing General Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 21 contracts
Sources: Underwriting Agreement (Jasper Therapeutics, Inc.), Underwriting Agreement (Aytu Biopharma, Inc), Underwriting Agreement (Aytu Biopharma, Inc)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Placement Shares as described in the Registration Statement, the Pricing Disclosure Package Statement and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 17 contracts
Sources: Sales Agreement (Ultragenyx Pharmaceutical Inc.), Sales Agreement (AVITA Medical, Inc.), Sales Agreement
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Offered Securities as described in the Registration Statement, the Pricing General Disclosure Package and the Final Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 14 contracts
Sources: Underwriting Agreement (Crescent Energy Co), Underwriting Agreement (Crescent Energy Co), Underwriting Agreement (FREYR Battery)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Placement Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 13 contracts
Sources: Sales Agreement (Senseonics Holdings, Inc.), Sales Agreement (COMPASS Pathways PLC), Sales Agreement (Athira Pharma, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities as described in the Registration Statement, the Pricing Disclosure Package Time of Sale Information and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 13 contracts
Sources: Underwriting Agreement (Comerica Inc /New/), Underwriting Agreement (Nevro Corp), Underwriting Agreement (Comerica Inc /New/)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities as described in the Registration Statement, the Pricing Disclosure Package Time of Sale Information and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System Board or any other regulation of such Board of Governorsthe Federal Reserve Board.
Appears in 11 contracts
Sources: Underwriting Agreement (Fifth Third Bancorp), Underwriting Agreement (Fifth Third Bancorp), Underwriting Agreement (Fifth Third Bancorp)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Placement Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 11 contracts
Sources: Equity Distribution Agreement (Spire Global, Inc.), Equity Distribution Agreement (Spire Global, Inc.), Equity Distribution Agreement (Clever Leaves Holdings Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities as described in the Registration Statement, the Pricing General Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 10 contracts
Sources: Underwriting Agreement (Aytu Biopharma, Inc), Underwriting Agreement (Aytu Biopharma, Inc), Underwriting Agreement (Aura Biosciences, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing General Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 8 contracts
Sources: Underwriting Agreement (Allot Ltd.), Underwriting Agreement (GH Research PLC), Underwriting Agreement (Inotiv, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 7 contracts
Sources: Underwriting Agreement (iRhythm Technologies, Inc.), Underwriting Agreement (iRhythm Technologies, Inc.), Underwriting Agreement (NMI Holdings, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package any Permitted Free Writing Prospectus and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 6 contracts
Sources: Distribution Agreement (Retail Properties of America, Inc.), Distribution Agreement (Retail Properties of America, Inc.), Distribution Agreement (Retail Properties of America, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities, as described in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 6 contracts
Sources: Underwriting Agreement (Exelon Corp), Underwriting Agreement (Exelon Corp), Underwriting Agreement (Exelon Corp)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities as described in each of the Registration Statement, the Pricing Disclosure Package Time of Sale Information and the Prospectus Offering Memorandum will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 6 contracts
Sources: Purchase Agreement (Callon Petroleum Co), Purchase Agreement (Callon Petroleum Co), Purchase Agreement (Callon Petroleum Co)
Margin Rules. The application of the proceeds received by the Company Partnership from the issuance, sale and delivery of the Shares Units as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 6 contracts
Sources: Underwriting Agreement (Carlyle Group L.P.), Underwriting Agreement (Carlyle Group L.P.), Underwriting Agreement (Ares Management Lp)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 5 contracts
Sources: Underwriting Agreement (Dynex Capital Inc), Underwriting Agreement (Dynex Capital Inc), Underwriting Agreement (Dynex Capital Inc)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities as described in the Registration Statement, the Pricing Disclosure Package Time of Sale Information and the Prospectus Offering Memorandum will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 5 contracts
Sources: Purchase Agreement (Ironwood Pharmaceuticals Inc), Purchase Agreement, Purchase Agreement (NantHealth, Inc.)
Margin Rules. The application of the proceeds received from the sale of the Shares to be sold by the Company from the issuance, sale and delivery of the Shares pursuant to this Agreement as described in the Registration Statement, the Pricing Disclosure Package Time of Sale Information and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 5 contracts
Sources: Underwriting Agreement (Approach Resources Inc), Underwriting Agreement (Approach Resources Inc), Underwriting Agreement (Approach Resources Inc)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Notes as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 5 contracts
Sources: Underwriting Agreement (Carlyle Group Inc.), Underwriting Agreement (Carlyle Group Inc.), Underwriting Agreement (Carlyle Group Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Placement Shares as described in the Registration Statement, the Pricing Disclosure Package Statement and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 5 contracts
Sources: Common Stock Sales Agreement (Avidity Biosciences, Inc.), Sales Agreement (Avidity Biosciences, Inc.), Sales Agreement (Avidity Biosciences, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus Offering Memorandum will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 5 contracts
Sources: Purchase Agreement (Oshkosh Corp), Purchase Agreement (Sonic Automotive Inc), Purchase Agreement (Oshkosh Corp)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 4 contracts
Sources: Underwriting Agreement (Strategic Hotels & Resorts, Inc), Underwriting Agreement (Strategic Hotels & Resorts, Inc), Underwriting Agreement (Strategic Hotels & Resorts, Inc)
Margin Rules. The application of the proceeds received by the Company from Neither the issuance, sale and delivery of the Shares by the Company nor the application of the proceeds thereof by the Company as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 4 contracts
Sources: Underwriting Agreement (IDEAYA Biosciences, Inc.), Underwriting Agreement (IDEAYA Biosciences, Inc.), Underwriting Agreement (IDEAYA Biosciences, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Units as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 4 contracts
Sources: Underwriting Agreement (Palatin Technologies Inc), Underwriting Agreement (Palatin Technologies Inc), Underwriting Agreement (EnteroMedics Inc)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 4 contracts
Sources: Underwriting Agreement (Sundial Growers Inc.), Underwriting Agreement (Sundial Growers Inc.), Underwriting Agreement (Sundial Growers Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Underwritten Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 4 contracts
Sources: Underwriting Agreement (Synovus Financial Corp), Underwriting Agreement (Synovus Financial Corp), Underwriting Agreement (Synovus Financial Corp)
Margin Rules. The application of the proceeds received by the Company from Neither the issuance, sale and delivery of the Shares nor the application of the proceeds thereof by the Company as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 4 contracts
Sources: Underwriting Agreement (Solid Biosciences Inc.), Underwriting Agreement (Cambium Networks Corp), Underwriting Agreement (Solid Biosciences, LLC)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 3 contracts
Sources: Open Market Sale Agreement (Sutro Biopharma, Inc.), Open Market Sale Agreement (Inhibrx, Inc.), Open Market Sale Agreement (Sutro Biopharma, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing General Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 3 contracts
Sources: Underwriting Agreement (Hudson Technologies Inc /Ny), Underwriting Agreement (Synthetic Biologics, Inc.), Underwriting Agreement (Hudson Technologies Inc /Ny)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus Prospectus, will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 3 contracts
Sources: Dealer Manager Agreement (First Security Group Inc/Tn), Dealer Manager Agreement (Bank of Florida Corp), Dealer Manager Agreement (Bank of Florida Corp)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package Time of Sale Prospectus and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 3 contracts
Sources: Underwriting Agreement (Corbus Pharmaceuticals Holdings, Inc.), Underwriting Agreement (Corbus Pharmaceuticals Holdings, Inc.), Underwriting Agreement (Corbus Pharmaceuticals Holdings, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package and or the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governorsthe Federal Reserve.
Appears in 3 contracts
Sources: Underwriting Agreement (OP Bancorp), Underwriting Agreement (OP Bancorp), Underwriting Agreement (OP Bancorp)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Offered Securities as described in the Registration Statement, the Pricing Disclosure Package Time of Sale Prospectus and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 3 contracts
Sources: Underwriting Agreement (Praxis Precision Medicines, Inc.), Underwriting Agreement (Praxis Precision Medicines, Inc.), Underwriting Agreement (Praxis Precision Medicines, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities as described in each of the Registration Statement, the Pricing Disclosure Package Time of Sale Information and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 3 contracts
Sources: Underwriting Agreement (NMI Holdings, Inc.), Underwriting Agreement (Oshkosh Corp), Underwriting Agreement (Oshkosh Corp)
Margin Rules. The application of the net proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 3 contracts
Sources: Underwriting Agreement (Cleveland-Cliffs Inc.), Underwriting Agreement (Cliffs Natural Resources Inc.), Underwriting Agreement (Cliffs Natural Resources Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities as described in the Registration Statement, the Pricing Disclosure Package Time of Sale Information and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System (the “Federal Reserve Board”) or any other regulation of such Board of GovernorsFederal Reserve Board.
Appears in 3 contracts
Sources: Underwriting Agreement (FNB Corp/Pa/), Underwriting Agreement (FNB Corp/Pa/), Underwriting Agreement (FNB Corp/Pa/)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Offered Securities as described in the Registration Statement, the Pricing General Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Milestone Pharmaceuticals Inc.), Underwriting Agreement (Milestone Pharmaceuticals Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Adverum Biotechnologies, Inc.), Underwriting Agreement (Adverum Biotechnologies, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package and Statement or the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Sales Agreement (Molecular Templates, Inc.), Sales Agreement (Molecular Templates, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governorsthe Federal Reserve.
Appears in 2 contracts
Sources: Underwriting Agreement (Hanover Bancorp, Inc. /NY), Underwriting Agreement (LINKBANCORP, Inc.)
Margin Rules. The application of the proceeds received by the Company from Neither the issuance, sale and delivery of the Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Medicines Co /De), Underwriting Agreement (Medicines Co /De)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Public Shares as described in the Registration Statement, the Pricing General Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Panacea Acquisition Corp. II), Underwriting Agreement (Panacea Acquisition Corp. II)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery issuance of the Shares and the sale of the Offered ADSs as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Trony Solar Holdings Co LTD), Underwriting Agreement (Ambow Education Holding Ltd.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, Prospectus or the Pricing Disclosure Package and the Prospectus Time of Sale Information will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Sales Agreement (Kala Pharmaceuticals, Inc.), Sales Agreement (Kala Pharmaceuticals, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Offered ADSs and the Shares represented thereby as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (ShangPharma Corp), Underwriting Agreement (Acquity Group LTD)
Margin Rules. The application of the proceeds received by the Company Company, if any, from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Boot Barn Holdings, Inc.), Underwriting Agreement (Boot Barn Holdings, Inc.)
Margin Rules. The application of the proceeds received by the Company from form the issuance, sale and delivery of the Shares as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Presidio, Inc.), Underwriting Agreement (Presidio, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares and the Warrants as described in the Registration Statement, the Pricing General Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Synthetic Biologics, Inc.), Placement Agency Agreement (Synthetic Biologics, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance of the Shares and the issuance, sale and delivery of the Shares Offered ADSs as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Criteo S.A.), Underwriting Agreement (Criteo S.A.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of by the Shares Company as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Sienna Biopharmaceuticals, Inc.), Underwriting Agreement (Sienna Biopharmaceuticals, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities as described in the Registration Statement, the Pricing General Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Tilray Brands, Inc.), Underwriting Agreement (Tilray, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares by the Company as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Altair Engineering Inc.), Underwriting Agreement (Altair Engineering Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Kinsale Capital Group, Inc.), Underwriting Agreement (Kinsale Capital Group, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Offered Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Underwriting Agreement (Stratasys Ltd.), Underwriting Agreement (Objet LTD)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Common Stock as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: At the Market Offering Agreement (CAPSTONE TURBINE Corp), Sales Agreement (CAPSTONE TURBINE Corp)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Issuance Shares or any Common Shares issued pursuant to any Forward Contract as described in the Registration Statement, the Pricing Disclosure Package Statement and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Equity Distribution Agreement (RPT Realty), Equity Distribution Agreement (RPT Realty)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package Time of Sale Information and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Open Market Sale Agreement (Bluebird Bio, Inc.), Underwriting Agreement (Nevro Corp)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities as described in the Registration Statement, the Pricing Disclosure Package Statement and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Open Market Sale Agreement (BigBear.ai Holdings, Inc.), Sales Agreement (BigBear.ai Holdings, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Placement Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 2 contracts
Sources: Common Stock Sales Agreement (Invitae Corp), Sales Agreement (Invitae Corp)
Margin Rules. The application of the proceeds received by the Company from Neither the issuance, sale and delivery of the Option Shares nor the application of the proceeds thereof by the Company as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Sources: Underwriting Agreement (Golden Entertainment, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Stock as described in the Registration Statement, the Pricing General Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 1 contract
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Depositary Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in each of the Registration Statement, the Pricing Disclosure Package Statement and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Sources: Equity Distribution Agreement (Onconova Therapeutics, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, issuance of the Shares and the sale and delivery of the Shares Offered ADSs as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Sources: Underwriting Agreement (China Auto Rental Holdings Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Offered Shares as described in the Registration Statement, the Pricing Disclosure Package Time of Sale Prospectus and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 1 contract
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Company Shares, if any, or the proceeds, if any, due upon settlement of the Forward Sale Agreement or any Additional Forward Sale Agreement, as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Sources: Underwriting Agreement (Hawaiian Electric Industries Inc)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors. 1 To be removed if no subsidiaries are formed.
Appears in 1 contract
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Company Shares and from settlement of the Forward Agreements, if any, in each case as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus Prospectus, will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Offered ADSs as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus Prospectuses will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Sources: Underwriting Agreement (SXC Health Solutions Corp.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System Board or any other regulation of such the Federal Reserve Board of Governorsapplicable to the Company.
Appears in 1 contract
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities as described in the Registration Statement, the Pricing General Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the U.S. Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 1 contract
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governorsthe Federal Reserve.
Appears in 1 contract
Sources: Underwriting Agreement (Priority Technology Holdings, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package Time of Sale Information and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of GovernorsSystem.
Appears in 1 contract
Sources: Underwriting Agreement (Synthesis Energy Systems Inc)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares New Securities as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus Prospectus, will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Sources: Dealer Manager Agreement (Great Elm Capital Group, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package and the or Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Sources: Underwriting Agreement (Impac Mortgage Holdings Inc)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Corporate Units, as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Sources: Underwriting Agreement (Exelon Corp)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package Time of Sale Information, the Prospectus and the any Issuer Free Writing Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governorsthe Federal Reserve.
Appears in 1 contract
Margin Rules. The application of the proceeds received by the Company from the issuance, sale issuance and delivery of the Borrowed Shares as described in the Registration Statement, the Pricing Disclosure Package Package, the Prospectus and the Prospectus Share Lending Agreement will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Prospectus and the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Sources: Underwriting Agreement (Melinta Therapeutics, Inc. /New/)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Prospectus, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governorsthe Federal Reserve.
Appears in 1 contract
Sources: Underwriting Agreement (Commercial Bancgroup, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Stock as described in the Registration Statement, the Pricing General Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of GovernorsSystem.
Appears in 1 contract
Sources: Underwriting Agreement (Nivalis Therapeutics, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package Time of Sale Prospectus and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 1 contract
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Units as described in the Registration Statement, the Pricing General Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 1 contract
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governorsthe Federal Reserve.
Appears in 1 contract
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System (the “Federal Reserve Board”) or any other regulation of such Board of Governorsthe Federal Reserve Board.
Appears in 1 contract
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Offered Shares as described in the Registration Statement, the Pricing General Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System system or any other regulation of such Board of Governors.
Appears in 1 contract
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus Final Prospectuses will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Standby Underwritten Shares, if any, or the proceeds due upon settlement of the Forward Agreement, if any, in each case, as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus Prospectus, will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, the Pricing Disclosure Package Statements and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Sources: Open Market Sale Agreement (Corbus Pharmaceuticals Holdings, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares as described in the Registration Statement, Prospectus or the Pricing Disclosure Package and the Prospectus Time of Sale Information will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors..
Appears in 1 contract
Sources: Open Market Sale Agreement (Kala Pharmaceuticals, Inc.)
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Securities by the Company as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Margin Rules. The application of the proceeds received by the Company from the issuance, sale and delivery of the Shares Shares, the application of the proceeds as described in each of the Registration Statement, the Pricing Disclosure Package Prospectus and the Prospectus Time of Sale Information will not violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.
Appears in 1 contract
Sources: Open Market Sale Agreement (Constellation Pharmaceuticals Inc)